Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients.
Status:
Not yet recruiting
Trial end date:
2025-11-01
Target enrollment:
Participant gender:
Summary
The STEMFOOT Pilot Study is a single center randomized open phase I clinical intervention
pilot trial with the aim of investigating the treatment effect of an allogenic
adipose-derived mesenchymal stromal cell product (C2C_ASC) compared to conventional optimal
treatment on healing and complications of foot ulcers in diabetes patients.